# ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

> **NCT06487585** · PHASE4 · RECRUITING · sponsor: **University of Maryland St. Joseph Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Vasodilatory Hypotension During or After Cardiac Surgery

## Interventions

- **DRUG:** Angiotensin II

## Key facts

- **NCT ID:** NCT06487585
- **Lead sponsor:** University of Maryland St. Joseph Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-01
- **Final completion:** 2026-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487585, "ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06487585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*